Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September

Sunshine Biopharma, Inc. (NASDAQ:SBFM - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 370,900 shares, a growth of 66.8% from the September 15th total of 222,300 shares. Approximately 30.4% of the company's shares are sold short. Based on an average daily trading volume, of 162,900 shares, the short-interest ratio is presently 2.3 days.

Sunshine Biopharma Price Performance

SBFM stock traded down $0.09 on Friday, hitting $2.97. 70,780 shares of the company were exchanged, compared to its average volume of 127,536. Sunshine Biopharma has a twelve month low of $2.42 and a twelve month high of $679.80. The business's fifty day moving average is $2.80 and its two-hundred day moving average is $2.22. The stock has a market capitalization of $69.53 million, a price-to-earnings ratio of -0.23 and a beta of 1.39.

Sunshine Biopharma (NASDAQ:SBFM - Get Free Report) last released its quarterly earnings results on Friday, August 16th. The company reported ($9.94) earnings per share for the quarter. The firm had revenue of $9.30 million for the quarter. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.